XML 15 R6.htm IDEA: XBRL DOCUMENT v3.5.0.2
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 9 Months Ended
Oct. 01, 2016
Oct. 03, 2015
Cash flows from operating activities:    
Net income $ 347,125 $ 317,999
Adjustments to reconcile net income to net cash provided by operating activities:    
Stock-based compensation expense 32,604 24,957
Deferred income taxes 4,924 1,821
Depreciation 38,854 33,202
Amortization of intangibles 33,510 33,693
Gain on sale of assets (1,500) (1,377)
Change in operating assets and liabilities, net of acquisitions:    
Decrease in accounts receivable 39,471 6,887
Increase in inventories (39,988) (35,488)
(Increase) decrease in other current assets (2,906) 2,183
Increase in other assets (4,667) (11,614)
(Decrease) increase in accounts payable and other current liabilities (29,179) 4,234
Increase in deferred revenue and customer advances 29,244 31,099
Increase (decrease) in other liabilities 8,611 (954)
Net cash provided by operating activities 456,103 406,642
Cash flows from investing activities:    
Additions to property, plant, equipment and software capitalization (72,296) (72,250)
Business acquisitions, net of cash acquired (5,654) (9,408)
Purchases of investments (1,923,054) (1,467,078)
Maturities and sales of investments 1,558,330 1,249,073
Proceeds from sale of assets 4,000 5,154
Net cash used in investing activities (438,674) (294,509)
Cash flows from financing activities:    
Proceeds from debt issuances 440,177 285,073
Payments on debt (325,323) (120,140)
Payments of debt issuance costs (1,705) (2,382)
Proceeds from stock plans 58,572 28,948
Purchases of treasury shares (241,924) (255,111)
Excess tax benefit related to stock option plans 12,914 5,689
(Payments for) proceeds from derivative contracts (9,525) 5
Net cash used in financing activities (66,814) (57,918)
Effect of exchange rate changes on cash and cash equivalents (8,071) (16,874)
(Decrease) increase in cash and cash equivalents (57,456) 37,341
Cash and cash equivalents at beginning of period 487,665 422,177
Cash and cash equivalents at end of period $ 430,209 $ 459,518